Inhibrx Inc (INBX)
11.52
-0.47 (-3.92%)
USD |
NASDAQ |
Jun 30, 13:03
Inhibrx Price: 11.52 for June 30, 2022
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jun 29, 2022 | 11.26 | 12.04 | 10.90 | 11.99 | 608638.0 |
Jun 28, 2022 | 11.99 | 12.30 | 11.38 | 11.39 | 446970.0 |
Jun 27, 2022 | 11.72 | 12.26 | 11.26 | 12.03 | 228904.0 |
Jun 24, 2022 | 11.48 | 11.80 | 10.33 | 11.72 | 585126.0 |
Jun 23, 2022 | 10.15 | 11.34 | 10.06 | 11.28 | 293464.0 |
Jun 22, 2022 | 9.55 | 10.30 | 9.23 | 10.07 | 261194.0 |
Jun 21, 2022 | 9.29 | 10.51 | 9.095 | 9.80 | 836260.0 |
Jun 17, 2022 | 8.76 | 9.31 | 8.615 | 9.08 | 2.575M |
Jun 16, 2022 | 8.60 | 9.28 | 7.67 | 8.56 | 707234.0 |
Jun 15, 2022 | 8.70 | 9.10 | 8.39 | 8.96 | 449548.0 |
Jun 14, 2022 | 8.94 | 9.03 | 8.08 | 8.52 | 424228.0 |
Jun 13, 2022 | 9.47 | 9.565 | 8.70 | 8.87 | 489111.0 |
Jun 10, 2022 | 11.23 | 11.50 | 9.65 | 9.82 | 343731.0 |
Jun 09, 2022 | 11.85 | 11.98 | 11.37 | 11.43 | 217673.0 |
Jun 08, 2022 | 11.66 | 12.63 | 11.43 | 12.02 | 181983.0 |
Jun 07, 2022 | 10.82 | 11.76 | 10.68 | 11.68 | 307551.0 |
Jun 06, 2022 | 11.89 | 12.00 | 10.66 | 10.95 | 272032.0 |
Jun 03, 2022 | 11.40 | 11.97 | 11.00 | 11.53 | 445468.0 |
Jun 02, 2022 | 11.17 | 11.69 | 10.92 | 11.55 | 513465.0 |
Jun 01, 2022 | 13.17 | 13.51 | 11.16 | 11.22 | 701251.0 |
May 31, 2022 | 13.54 | 13.54 | 12.63 | 13.07 | 482164.0 |
May 27, 2022 | 13.03 | 13.68 | 12.60 | 13.65 | 272211.0 |
May 26, 2022 | 12.64 | 13.20 | 12.20 | 12.87 | 268499.0 |
May 25, 2022 | 12.37 | 12.81 | 11.90 | 12.57 | 318553.0 |
May 24, 2022 | 12.95 | 13.00 | 12.00 | 12.36 | 389327.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.52
Minimum
Jun 14 2022
50.00
Maximum
Dec 17 2020
26.26
Average
25.03
Median
Price Benchmarks
Cara Therapeutics Inc | 9.52 |
iBio Inc | 0.279 |
Synthetic Biologics Inc | 0.2025 |
NovaBay Pharmaceuticals Inc | 0.232 |
Palatin Technologies Inc | 0.2811 |
Price Related Metrics
PS Ratio | 61.52 |
PEG Ratio | -0.5643 |
Price to Book Value | 16.44 |
Earnings Yield | -21.18% |
Market Cap | 449.71M |
PEGY Ratio | -0.5643 |